E. Roman Et Al. , "Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.," Clinical cancer research : an official journal of the American Association for Cancer Research , vol.11, no.19 Pt 2, 2005
Roman, E. Et Al. 2005. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.. Clinical cancer research : an official journal of the American Association for Cancer Research , vol.11, no.19 Pt 2 .
Roman, E., Cooney, E., Harrison, L., Militano, O., Wolownik, K., Hawks, R., ... Foley, S.(2005). Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.. Clinical cancer research : an official journal of the American Association for Cancer Research , vol.11, no.19 Pt 2.
Roman, E Et Al. "Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.," Clinical cancer research : an official journal of the American Association for Cancer Research , vol.11, no.19 Pt 2, 2005
Roman, E Et Al. "Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.." Clinical cancer research : an official journal of the American Association for Cancer Research , vol.11, no.19 Pt 2, 2005
Roman, E. Et Al. (2005) . "Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.." Clinical cancer research : an official journal of the American Association for Cancer Research , vol.11, no.19 Pt 2.
@article{article, author={E Roman Et Al. }, title={Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.}, journal={Clinical cancer research : an official journal of the American Association for Cancer Research}, year=2005}